StocksBio-Rad Laboratories IncBIO

BIO

Bio-Rad Laboratories Inc

572.05 -2.88 (-0.50%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
570.89
B
573.16

Overview

Prev Close572.05
Day's Range563.78 - 586.93
52 Week Range539.51 - 831.47
Average Volume (3m)136.89K
1-Year Return4.36%
Beta0.7576
Market Cap17.11B
P/E Ratio2.59
Revenue2.98B
EPS220.4771
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.712/08/202126/10/202106/01/2022600.00650.00700.00750.00800.00850.00
Chart times in UTC
Industry Medical Specialties
CEO Norman D. Schwartz
Employees 8,000

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2020: Bio-Rad Laboratories Inc's revenues increased by 10.12% and amounted to 2.55B. Net income increased by 116.43% to 3.81B. Net assets increased by 71.67% to 9.88B and EPS increased from 58.27 to 126.20.
BIO's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
57.89%
Net Profit Margin
61.81%
Operating Margin
20.75%
Return On Investment
19.80%
12/20
03/21
06/21
09/21
Total Revenue
789.84M
726.8M
715.93M
747.05M
Gross Profit
460.16M
374.83M
407.45M
446.24M
Operating Income
167.94M
133.42M
125.72M
163.22M
Net Income
839.1M
977.41M
914.11M
3.93B